T-1201

· Taivex Therapeutics Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T-1201, covering 2025-05-30 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors [Phase 1]